SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | LABORATORY CORP OF AMERICA HOLDINGS | 9,745,265 | 11.5% | EDGAR |
SC 13G/A | 2024-01-30 | BlackRock Inc. | LABORATORY CORP OF AMERICA HOLDINGS | 10,488,875 | 12.4% | EDGAR |
SC 13D/A | 2023-07-24 | LABORATORY CORP OF AMERICA HOLDINGS | ENZO BIOCHEM INC | 0 | 0.0% | EDGAR |
SC 13D | 2023-03-27 | LABORATORY CORP OF AMERICA HOLDINGS | ENZO BIOCHEM INC | 4,862,730 | 9.8% | EDGAR |
SC 13G/A | 2023-02-10 | BlackRock Inc. | LABORATORY CORP OF AMERICA HOLDINGS | 11,474,507 | 13.0% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | LABORATORY CORP OF AMERICA HOLDINGS | 10,450,115 | 11.8% | EDGAR |
SC 13G/A | 2023-01-26 | BlackRock Inc. | LABORATORY CORP OF AMERICA HOLDINGS | 11,474,507 | 13.0% | EDGAR |
SC 13G/A | 2023-01-20 | BlackRock Inc. | LABORATORY CORP OF AMERICA HOLDINGS | 11,474,507 | 13.0% | EDGAR |
SC 13G/A | 2022-03-09 | BlackRock Inc. | LABORATORY CORP OF AMERICA HOLDINGS | 9,706,541 | 10.4% | EDGAR |
SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | LABORATORY CORP OF AMERICA HOLDINGS | 10,753,065 | 11.2% | EDGAR |
SC 13G/A | 2022-02-01 | BlackRock Inc. | LABORATORY CORP OF AMERICA HOLDINGS | 8,274,411 | 8.6% | EDGAR |
SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | LABORATORY CORP OF AMERICA HOLDINGS | 10,405,602 | 10.7% | EDGAR |
SC 13G/A | 2021-01-29 | BlackRock Inc. | LABORATORY CORP OF AMERICA HOLDINGS | 7,832,565 | 8.0% | EDGAR |
SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | LABORATORY CORP OF AMERICA HOLDINGS | 10,891,852 | 11.2% | EDGAR |
SC 13G/A | 2020-02-05 | BlackRock Inc. | LABORATORY CORP OF AMERICA HOLDINGS | 8,855,703 | 9.1% | EDGAR |
SC 13G/A | 2019-04-10 | BlackRock Inc. | LABORATORY CORP OF AMERICA HOLDINGS | 10,029,286 | 10.2% | EDGAR |
SC 13G/A | 2019-02-12 | Boston Partners | LABORATORY CORP OF AMERICA HOLDINGS | 3,300,143 | 3.3% | EDGAR |
SC 13G/A | 2019-02-11 | VANGUARD GROUP INC | LABORATORY CORP OF AMERICA HOLDINGS | 10,880,743 | 10.8% | EDGAR |
SC 13G/A | 2019-02-06 | BlackRock Inc. | LABORATORY CORP OF AMERICA HOLDINGS | 9,772,113 | 9.7% | EDGAR |
SC 13G | 2018-02-13 | Boston Partners | LABORATORY CORP OF AMERICA HOLDINGS | 5,324,442 | 5.2% | EDGAR |